The innate immune response in SARS-CoV2 infection: focus on toll-like receptor 4 in severe disease outcomes. [PDF]
Maggi E +7 more
europepmc +1 more source
Light-triggered toll-like receptor activation in a nanoscale metal-organic framework for synergistic PDT and cancer immunotherapy. [PDF]
Mao Y +7 more
europepmc +1 more source
Corrigendum: Pharmacological Inhibition of Macrophage Toll-like Receptor 4/Nuclear Factor-kappa B Alleviates Rhabdomyolysis-induced Acute Kidney Injury. [PDF]
europepmc +1 more source
Retraction Note: Toll-like receptor 9 agonist IMO cooperates with everolimus in renal cell carcinoma by interfering with tumour growth and angiogenesis. [PDF]
Damiano V +12 more
europepmc +1 more source
Urothelial collective-gliding response acts as a toll-like receptor 4-associated defense mechanism. [PDF]
Zhang N +17 more
europepmc +1 more source
Necrotizing Enterocolitis: A Comprehensive Review on Toll-like Receptor 4-Mediated Pathophysiology, Clinical, and Therapeutic Insights. [PDF]
Ishiyama A +5 more
europepmc +1 more source
Downregulation of Toll-Like Receptor Gene Expression Among Hepatitis B Virus-Positive Human Patients. [PDF]
Hussein TH +4 more
europepmc +1 more source
Albumin does not induce IL-6 release and toll-like receptor activation in vitro: Role of endotoxin contamination and biochemical modifications. [PDF]
Paar M +8 more
europepmc +1 more source

